Quadrature Capital’s Anterix ATEX Stock Holding History

Quadrature Capital’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	12,979 -1,523	-11%	-$89.4K	0.01%	641
2026 Q1	$554K	Buy	+14,502	New	+$459K	0.01%	760

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Quadrature Capital's ATEX Position: Q2 2026 in Review

Quadrature Capital reduced its Anterix (ATEX) stake by 11% in Q2 2026, selling an estimated $89.4K and leaving 12,979 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #641.

Quadrature Capital first reported a position in ATEX in Q1 2026 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

Quadrature Capital held 12,979 shares of Anterix worth $1.34M as of Q2 2026.
Quadrature Capital sold 1,523 Anterix shares in Q2 2026, an estimated $89.4K.
Anterix made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #641 holding.
Quadrature Capital first reported a position in Anterix in Q1 2026 and has held it in 2 quarters since.
171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.